Parent Perspectives on Complex Needs in Patients With MCT8 Deficiency: An International, Prospective, Registry Study

J Clin Endocrinol Metab. 2023 Dec 21;109(1):e330-e335. doi: 10.1210/clinem/dgad412.

Abstract

Context: Monocarboxylate transporter 8 (MCT8) deficiency is a rare neurodevelopmental and metabolic disorder, with daily care posing a heavy burden on caregivers. A comprehensive overview of these complex needs and daily care challenges is lacking.

Design: We established an international prospective registry to systemically capture data from parents and physicians caring for patients with MCT8 deficiency. Parent-reported data on complex needs and daily care challenges were extracted.

Results: Between July 17, 2018, and May 16, 2022, 51 patients were registered. Difficulties in daily life care were mostly related to feeding and nutritional status (17/33 patients), limited motor skills (12/33 patients), and sleeping (11/33 patients). Dietary advice was provided for 11/36 patients. Two of 32 patients were under care of a cardiologist. Common difficulties in the diagnostic trajectory included late diagnosis (20/35 patients) and visiting a multitude of specialists (15/35 patients). Median diagnostic delay was significantly shorter in patients born in or after 2017 vs before 2017 (8 vs 19 months, P < .0001).

Conclusions: Feeding and sleeping problems and limited motor skills mostly contribute to difficulties in daily care. The majority of patients did not receive professional dietary advice, although being underweight is a key disease feature, strongly linked with poor survival. Despite sudden death being a prominent cause of death, potentially related to the cardiovascular abnormalities frequently observed, patients were hardly seen by cardiologists. These findings can directly improve patient-centered multidisciplinary care and define patient-centered outcome measures for intervention studies in patients with MCT8 deficiency.

Keywords: AHDS; Allan-Herndon-Dudley syndrome; MCT8 deficiency; daily care; parents’ perspectives; patient registry.

MeSH terms

  • Delayed Diagnosis
  • Humans
  • Mental Retardation, X-Linked*
  • Monocarboxylic Acid Transporters
  • Muscle Hypotonia
  • Muscular Atrophy
  • Symporters*

Substances

  • Monocarboxylic Acid Transporters
  • Symporters

Supplementary concepts

  • Allan-Herndon-Dudley syndrome